Prediction of Key Candidate Genes for Platinum Resistance in Ovarian Cancer
Kaidi Guo,1,2,* Li Li1,2,* 1Department of Gynecology and Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, People’s Republic of China; 2Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, P...
Enregistré dans:
Auteurs principaux: | Guo K, Li L |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/762e86e1a5de49bf8a93a5bd591ac1af |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer
par: Wenwen Wang, et autres
Publié: (2021) -
Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis
par: Wenqiong Qin, et autres
Publié: (2021) -
Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis
par: Zhang X, et autres
Publié: (2021) -
High Serpin Family A Member 10 Expression Confers Platinum Sensitivity and Is Associated With Survival Benefit in High-Grade Serous Ovarian Cancer: Based on Quantitative Proteomic Analysis
par: Wenwen Guo, et autres
Publié: (2021) -
Epigenetic Therapy Augments Classic Chemotherapy in Suppressing the Growth of 3D High-Grade Serous Ovarian Cancer Spheroids over an Extended Period of Time
par: Michelle Bilbao, et autres
Publié: (2021)